{
    "2020-11-06": [
        [
            {
                "time": "2020-11-04",
                "original_text": "Novo Nordisk, Trading Near Highs, Announces $1.8 Billion Acquisition",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Trading Near Highs",
                        "Acquisition",
                        "$1.8 Billion"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-11-05",
                "original_text": "Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Trading",
                        "Board Members",
                        "Executives",
                        "Associated Persons"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-05",
                "original_text": "(EMIS) Alert: Johnson Fistel Investigates Proposed Sale of Emisphere; Are Shareholders Getting a Fair Deal?",
                "features": {
                    "keywords": [
                        "EMIS",
                        "Johnson Fistel",
                        "Proposed Sale",
                        "Emisphere",
                        "Shareholders",
                        "Fair Deal"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-11-05",
                "original_text": "Novo Nordisk to boost pill-form diabetic drugs with $1.8 billion deal",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Pill-Form",
                        "Diabetic Drugs",
                        "$1.8 Billion Deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}